Photo
June 11, 2022
Athena Countouriotis
President
Chief Executive Officer
Turning Point Therapeutics, Inc
Stories this photo appears in:
Bristol Myers Squibb Buys Turning Point
BIOTECH: $4.1B Deal Expands ‘Oncology Franchise’
Bristol Myers Squibb (BMS) is further strengthening its ties to San Diego. On June 3, the New York-based global biopharmaceutical company announced it had acquired Turning Point Therapeutics, Inc., a clinical-stage precision oncology company based in San Diego.